Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. GOSS
GOSS logo

GOSS News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

GOSS News

Harbour BioMed Appoints Dr. Luisa Salter-Cid as Scientific Advisor

Jun 11 2026Yahoo Finance

Class Action Filed Against Gossamer Bio for Securities Violations

Jun 01 2026Globenewswire

Class Action Lawsuits Reminder for Shareholders

Jun 01 2026Globenewswire

Gossamer Bio Faces Securities Class Action Lawsuit

Jun 01 2026PRnewswire

Gossamer Bio Faces Class Action Lawsuit Reminder

May 31 2026Globenewswire

Gossamer Bio Faces Class Action Lawsuit Over Trial Failures

May 31 2026Globenewswire

Reminder of Gossamer Bio Securities Class Action

May 30 2026Globenewswire

Gossamer Bio Faces Securities Class Action Lawsuit

May 30 2026PRnewswire

GOSS Events

06/17 08:30
Gossamer Bio Completes $72M Convertible Note Exchange
Gossamer Bio announced the final tender results of its previously announced exchange offer to exchange any and all of its 5.00% Convertible Senior Notes due 2027 for a pro rata portion of up to $72M in aggregate principal amount of its new 7.50% Convertible Senior Secured First Lien Notes due 2030, up to 317,647,058 shares of its common stock or, in lieu of issuing shares of Common Stock to the extent such shares would cause any holders of Existing Convertible Notes that are "qualified institutional buyers" as defined in Rule 144A under the Securities Act to beneficially own greater than 9.99% of the outstanding Common Stock, prefunded warrants to purchase shares of Common Stock and with respect to Eligible Holders who tender prior to the Extended Early Tender Date, warrants to purchase shares of Common Stock. As previously announced, as of 5:00 p.m., New York City time, on June 2, $181,052,000 in aggregate principal amount of Existing Convertible Notes was validly tendered in the Exchange Offer and not validly withdrawn and related consents to the Proposed Amendments were validly delivered and not validly withdrawn as of such time, and the Company and the Required Supporting Noteholders agreed to amend the condition to the Exchange Offer that a minimum of 98% of the aggregate principal amount of Existing Convertible Notes be validly tendered to a minimum of 90.5% of the aggregate principal amount of Existing Convertible Notes be validly tendered. As a result, early settlement of Offered Securities in exchange for the Early Tendered Notes validly tendered and not validly withdrawn as of the Extended Early Tender Date occurred on June 4, 2026, and the Company entered into a supplemental indenture eliminating substantially all of the restrictive covenants in the indenture governing the Existing Convertible Notes, as well as certain events of default and related provisions applicable to the Existing Convertible Notes. As of 5:00 p.m., New York City time, on June 16, 2026, based on information provided by D.F. King & Co., Inc., which is acting as the exchange agent and information agent for the Exchange Offer, no additional Existing Convertible Notes were validly tendered in the Exchange Offer. As a result, $18,948,000 in aggregate principal amount of the Existing Convertible Notes will remain outstanding following this Exchange Offer.

GOSS Monitor News

Gossamer Bio Faces Class Action Lawsuit Over Trial Failures

May 18 2026

Gossamer Bio's Phase 3 Trial Results Disappoint

Feb 23 2026

GOSS Earnings Analysis

No Data

No Data

People Also Watch